• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素通过靶向 Akt 促进 cyclin D1 的翻译抑制,从而诱导乳腺癌细胞 G1 期阻滞和凋亡。

Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.

机构信息

School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, West Bengal, India.

出版信息

Life Sci. 2013 Nov 13;93(21):783-90. doi: 10.1016/j.lfs.2013.09.009. Epub 2013 Sep 15.

DOI:10.1016/j.lfs.2013.09.009
PMID:24044882
Abstract

AIM

Thymoquinone (TQ), the predominant bioactive constituent of black seed oil (Nigella Sativa), has been shown to possess antineoplastic activity against multifarious tumors. However, the meticulous mechanism of TQ on Akt mediated survival pathway is still unrevealed in breast cancer. Here, we investigated TQ's mechanism of action against PI3K/Akt signaling and its downstream targets by modulating proteins translational machinery, leading to apoptosis in cancer cells.

MAIN METHODS

MDA-MB-468 and T-47D cells were treated with TQ and evaluated for its anticancer activity through phase distribution and western blot. Modulatory effects of TQ on Akt were affirmed through kinase and drug potential studies.

KEY FINDINGS

Studies revealed G1 phase arrest till 24h incubation with TQ while extended exposure showed phase shift to subG1 indicating apoptosis, supported by suppression of cyclin D1, cyclin E and cyclin dependent kinase inhibitor p27 expression. Immunoblot and membrane potential studies revealed mitochondrial impairment behind apoptotic process with upregulation of Bax, cytoplasmic cytochrome c and procaspase-3, PARP cleavage along with Bcl-2, Bcl-xL and survivin downregulation. Moreover, we construed the rationale behind mitochondrial dysfunction by examining the phosphorylation status of PDK1, PTEN, Akt, c-raf, GSK-3β and Bad in TQ treated cells, thus ratifying the involvement of Akt in apoptosis. Further, the consequential effect of Akt inhibition by TQ is proven by translational repression through deregulated phosphorylation of 4E-BP1, eIF4E, S6R and p70S6K.

SIGNIFICANCE

Our observations for the first time may provide a new insight for the development of novel therapies for Akt overexpressed breast cancer by TQ.

摘要

目的

黑种草籽油(Nigella Sativa)中的主要生物活性成分百里醌(TQ)已被证明对多种肿瘤具有抗肿瘤活性。然而,TQ 在 Akt 介导的存活途径中的细致机制在乳腺癌中仍未被揭示。在这里,我们通过调节蛋白质翻译机制来研究 TQ 对 PI3K/Akt 信号及其下游靶标的作用,从而导致癌细胞凋亡。

主要方法

用 TQ 处理 MDA-MB-468 和 T-47D 细胞,并通过相位分布和 Western blot 评估其抗癌活性。通过激酶和药物潜力研究证实了 TQ 对 Akt 的调节作用。

主要发现

研究表明,用 TQ 孵育 24 小时可导致 G1 期停滞,而延长暴露则显示出向 subG1 的相位转移,表明凋亡,这得到了细胞周期蛋白 D1、细胞周期蛋白 E 和细胞周期蛋白依赖性激酶抑制剂 p27 表达抑制的支持。免疫印迹和膜电位研究显示,凋亡过程背后的线粒体损伤伴随着 Bax、细胞质细胞色素 c 和 procaspase-3 的上调,PARP 裂解以及 Bcl-2、Bcl-xL 和 survivin 的下调。此外,我们通过检查 TQ 处理细胞中 PDK1、PTEN、Akt、c-raf、GSK-3β 和 Bad 的磷酸化状态来推断线粒体功能障碍的原理,从而证实 Akt 在凋亡中的参与。此外,通过 TQ 对 Akt 的抑制作用来证明翻译抑制作用,通过对 4E-BP1、eIF4E、S6R 和 p70S6K 的去调节磷酸化来证明。

意义

我们的观察结果首次可能为 TQ 对 Akt 过表达乳腺癌的新型治疗方法的开发提供新的见解。

相似文献

1
Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.姜黄素通过靶向 Akt 促进 cyclin D1 的翻译抑制,从而诱导乳腺癌细胞 G1 期阻滞和凋亡。
Life Sci. 2013 Nov 13;93(21):783-90. doi: 10.1016/j.lfs.2013.09.009. Epub 2013 Sep 15.
2
Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.百里醌是黑种草籽的一种生物活性成分,可导致具有突变型p53的三阴性乳腺癌细胞发生G1期细胞周期阻滞和凋亡。
Nutr Cancer. 2014;66(3):408-18. doi: 10.1080/01635581.2013.878739. Epub 2014 Feb 28.
3
Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.胸腺醌上调 PTEN 表达并诱导多柔比星耐药的人乳腺癌细胞凋亡。
Mutat Res. 2011 Jan 10;706(1-2):28-35. doi: 10.1016/j.mrfmmm.2010.10.007. Epub 2010 Oct 30.
4
Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer.姜黄素和他莫昔芬对 XIAP 介导的 Akt 调节的乳腺癌靶向凋亡作用。
PLoS One. 2013 Apr 17;8(4):e61342. doi: 10.1371/journal.pone.0061342. Print 2013.
5
LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.LYG-202 对人乳腺癌细胞的 PI3K/Akt 信号通路发挥抗肿瘤作用。
Apoptosis. 2015 Sep;20(9):1253-69. doi: 10.1007/s10495-015-1145-x.
6
Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.姜黄素作为一种抗癌剂:体外抑制癌细胞活力和侵袭以及体内肿瘤生长的证据。
Fundam Clin Pharmacol. 2013 Oct;27(5):557-69. doi: 10.1111/j.1472-8206.2012.01056.x. Epub 2012 Jul 13.
7
Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells.百里醌增强环磷酰胺介导的对乳腺癌细胞增殖的抑制作用。
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1153-1160. doi: 10.31557/APJCP.2019.20.4.1153.
8
Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase.百里醌通过阻断JAK2和Src介导的表皮生长因子受体酪氨酸激酶磷酸化使信号转导和转录激活因子3失活,从而诱导人结肠癌HCT116细胞凋亡。
Oncol Rep. 2014 Aug;32(2):821-8. doi: 10.3892/or.2014.3223. Epub 2014 May 29.
9
Thymoquinone-induced reactive oxygen species causes apoptosis of chondrocytes via PI3K/Akt and p38kinase pathway.胸腺醌诱导活性氧引起软骨细胞凋亡通过 PI3K/Akt 和 p38 激酶通路。
Exp Biol Med (Maywood). 2013 Jul;238(7):811-20. doi: 10.1177/1535370213492685. Epub 2013 Jun 20.
10
Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.雌马酚通过调节Akt信号通路抑制人胃癌细胞的增殖。
World J Gastroenterol. 2015 Sep 28;21(36):10385-99. doi: 10.3748/wjg.v21.i36.10385.

引用本文的文献

1
Novel strategy for activating gene expression through triplex DNA formation targeting epigenetically suppressed genes.通过靶向表观遗传抑制基因形成三链 DNA 来激活基因表达的新策略。
RSC Chem Biol. 2024 Jul 31;5(9):884-890. doi: 10.1039/d4cb00134f. eCollection 2024 Aug 28.
2
Antimicrobial, Antioxidant and Cytotoxic Effects of Essential Oil, Fatty Acids and Bioactive Compounds of var. (Fodder Beet).饲用甜菜变种的精油、脂肪酸及生物活性化合物的抗菌、抗氧化和细胞毒性作用
Indian J Microbiol. 2024 Jun;64(2):719-731. doi: 10.1007/s12088-024-01269-8. Epub 2024 Apr 16.
3
Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer.
百里醌:一种用于治疗结直肠癌的有前景的治疗药物。
Curr Issues Mol Biol. 2023 Dec 23;46(1):121-139. doi: 10.3390/cimb46010010.
4
Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer.黑种草醌在结直肠癌中的潜在抗癌特性及机制
Cancer Cell Int. 2023 Dec 12;23(1):320. doi: 10.1186/s12935-023-03174-4.
5
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients.姜黄素,一种新型多靶点抗肿瘤乳腺癌(BC)标志物抑制剂:CALR、NLRP3 通路和 HR+ 和三阴性乳腺癌(TNBC)患者 PBMCs 中的 sPD-L1。
Int J Mol Sci. 2023 Sep 19;24(18):14254. doi: 10.3390/ijms241814254.
6
Exploring the Potent Anticancer Activity of Essential Oils and Their Bioactive Compounds: Mechanisms and Prospects for Future Cancer Therapy.探索精油及其生物活性化合物的强大抗癌活性:作用机制及未来癌症治疗的前景
Pharmaceuticals (Basel). 2023 Jul 31;16(8):1086. doi: 10.3390/ph16081086.
7
Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review.探讨膳食植物化学物对乳腺癌患者的抗癌潜力:全面综述。
Cancer Med. 2023 Jul;12(13):14556-14583. doi: 10.1002/cam4.5984. Epub 2023 May 3.
8
Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells.通过抗氧化活性、上调 Nrf2 和下调 PD-L1,百里醌对三阴性乳腺癌细胞的抗癌作用。
Nutrients. 2022 Nov 13;14(22):4787. doi: 10.3390/nu14224787.
9
Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines' Progression.姜黄素和百里醌联合抑制乳腺癌细胞系的进展。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221099537. doi: 10.1177/15347354221099537.
10
Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives.乳腺癌治疗中植物化学物质的机制评估:当前认识与未来展望
RSC Adv. 2018 Aug 22;8(52):29714-29744. doi: 10.1039/c8ra04879g. eCollection 2018 Aug 20.